Cents and Sensibility - Kimberly and Friends' Consortium Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jack Hartmann who wrote (51659)	12/27/1999 11:10:00 PM
From: EtTuBrute	of 108040

BIME: Looks like an earnings play. Looks like the company is going to record a good profit, not bad for a $1 biotech NASDAQ company with only 2 million shares out. Already have through 3 quarters .15/sh profit: LOS ANGELES (CBS.MW) -- Biomune Systems soared 61 percent Monday ahead of the company's fourth-quarter earnings report. Today on CBS MarketWatch Nasdaq ekes out record gain Investors roil Amazon.com shares Upgrade lifts Knight/Trimark shares CDNow hits 3 mln holiday customers StockWatch: An eye on the January effect, Part I More top stories... CBS MarketWatch Columns Updated: 12/27/99 5:22:50 PM ET Could it be the fundamentals and earnings? According to Market Guide, the company (BIME: news, msgs) recorded a loss of $34.49 a share for 1996, a loss of $52.34 a share in 1997 and a loss of $6.88 a share in 1998. However, the biopharmaceutical products company is on its way to reporting a positive number for 1999. The company posted a first-quarter profit of 5 cents, a second-quarter profit of 6 cents a share and a third-quarter profit of 4 cents a share. The company is slated to report fourth-quarter earnings Dec. 29 Shares were last trading up 17/32 to close at 1 13/32.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next